Retrospective drug utilization review: impact of pharmacist interventions on physician prescribing

Figures & data

Table 1 Number of nonrepetitive interventions per prescriber

Number of nonrepetitive interventions	Cases	Controls
1	14,210 (62.1%)	930 (39.6%)
2–5	7985 (34.9%)	1088 (46.3%)
6–10	550 (2.4%)	249 (10.6%)
11–20	111 (0.5%)	78 (3.3%)
20+	14 (0.1%)	3 (0.1%)

Table 2 Nonrepetitive conflicts intervened

Nonrepetitive conflict type	Cases (N = 32,780)	Controls (N = 7069)
Therapeutic appropriateness	8277 (25.3%)	1117 (15.8%)
Therapeutic duplication	5641 (17.2%)	1096 (15.5%)
Underuse precaution	6076 (18.5%)	1057 (15.1%)
Drug–drug interaction	5823 (17.8%)	1796 (25.4%)
High dose	2703 (8.2%)	684 (9.7%)
Drug–disease precaution	2347 (7.2%)	504 (7.1%)
Overuse precaution	1913 (5.8%)	815 (11.5%)